Literature DB >> 2790381

Pronounced cholinergic but only moderate purinergic effects in isolated atrial and ventricular heart muscle from cats.

M Kemmer1, H Jakob, H Nawrath.   

Abstract

1. The effects of cholinergic and purinergic stimulation on action potential, force of contraction and 86Rb efflux were investigated in cat atrial and/or ventricular heart muscle. 2. Acetylcholine and carbachol exerted a concentration-dependent negative inotropic effect in cat atrial heart muscle. Carbachol 10 mumol l-1 completely abolished the force of contraction and increased the rate constant of 86Rb efflux 2-3 fold, whereas the action potential duration was shortened to about 1/10 of its length under control conditions. 3. The effects of acetylcholine and carbachol in cat atrial heart muscle were mimicked, qualitatively, by adenosine and its analogues 5'-(N-ethyl)-carboxamido-adenosine (NECA) and (-)-N6-(R-phenyl-isopropyl)-adenosine (R-PIA). Maximal purinergic effects, however, amounted to about 15-50% in comparison to those of cholinergic stimulation. 4. In cat ventricular heart muscle, cholinergic or purinergic stimulation had no significant effects on the force of contraction in the absence of a cyclic AMP-dependent positive inotropic effect. Carbachol antagonized the positive inotropic effect elicited by either 3-isobutyl-1-methylxanthine, isoprenaline or cyclic 8-(4-chlorphenylthio)adenosine-3':5'-monophosphate; NECA and R-PIA were less effective. The inhibition by carbachol of the effects of isoprenaline was not related to a change in the rate constant of 86Rb efflux. 5. It is concluded that the effects of cholinoceptor and purinoceptor agonists in the cat heart involve a change in the potassium conductance in the atrium, whereas the effects in the ventricle may be related to changes of intracellular cyclic AMP levels. It seems reasonable to assume that, in comparison to cholinergic stimulation, a low density of purinoceptors in the cat heart is responsible for the relatively weak effects of adenosine agonists in this species.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2790381      PMCID: PMC1854613          DOI: 10.1111/j.1476-5381.1989.tb12578.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

1.  EFFECTS OF CAFFEINE ON MAMMALIAN ATRIAL MUSCLE, AND ITS INTERACTION WITH ADENOSINE AND CALCIUM.

Authors:  T DEGUBAREFF; W SLEATOR
Journal:  J Pharmacol Exp Ther       Date:  1965-05       Impact factor: 4.030

2.  Effects of papaverine and its interaction with isoprenaline and carbachol on the contractile force and cyclic nucleotide levels of the canine ventricular myocardium.

Authors:  M Endoh; M Honma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-04       Impact factor: 3.000

3.  Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3',5'-monophosphate formation and glycogen phosphorylase activity in rat heart muscle.

Authors:  J G Dobson
Journal:  Circ Res       Date:  1978-11       Impact factor: 17.367

Review 4.  The parasympathetic neuroeffector junction of the heart.

Authors:  K Löffelholz; A J Pappano
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

5.  Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines.

Authors:  A M Watanabe; M M McConnaughey; R A Strawbridge; J W Fleming; L R Jones; H R Besch
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

6.  Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells.

Authors:  H C Hartzell; R Fischmeister
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

7.  Evidence for an A1-adenosine receptor in the guinea-pig atrium.

Authors:  M G Collis
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

8.  Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.

Authors:  M Böhm; R Brückner; I Hackbarth; B Haubitz; R Linhart; W Meyer; B Schmidt; W Schmitz; H Scholz
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

9.  Inhibition by purines of the inotropic action of isoprenaline in rat atria.

Authors:  P R Hughes; T W Stone
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

10.  On the ionic mechanism underlying adrenergic-cholinergic antagonism in ventricular muscle.

Authors:  I Josephson; N Sperelakis
Journal:  J Gen Physiol       Date:  1982-01       Impact factor: 4.086

View more
  2 in total

1.  Pharmacological characteristics of adenosine-induced inhibition of dog ventricular contractility: dependence on the pre-existing level of beta-adrenoceptor activation.

Authors:  M Endoh; H Kushida; I Norota; M Takanashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

2.  Functional role of cholinoceptors and purinoceptors in human isolated atrial and ventricular heart muscle.

Authors:  H Jakob; H Oelert; J Rupp; H Nawrath
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.